U.S. markets closed
  • S&P 500

    3,310.11
    +39.08 (+1.19%)
     
  • Dow 30

    26,659.11
    +139.16 (+0.52%)
     
  • Nasdaq

    11,185.59
    +180.72 (+1.64%)
     
  • Russell 2000

    1,561.58
    +18.30 (+1.19%)
     
  • Crude Oil

    36.11
    -1.28 (-3.42%)
     
  • Gold

    1,867.90
    -11.30 (-0.60%)
     
  • Silver

    23.33
    -0.03 (-0.15%)
     
  • EUR/USD

    1.1678
    -0.0071 (-0.61%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • GBP/USD

    1.2923
    -0.0064 (-0.49%)
     
  • USD/JPY

    104.6150
    +0.3140 (+0.30%)
     
  • BTC-USD

    13,462.04
    -80.88 (-0.60%)
     
  • CMC Crypto 200

    264.65
    +21.97 (+9.05%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,331.94
    -86.57 (-0.37%)
     

Genmark Diagnostics Inc (GNMK) CFO John Frederick Ek Sold $569,329 of Shares

GuruFocus.com
·2 mins read

- By insider

CFO of Genmark Diagnostics Inc (30-Year Financial, Insider Trades) John Frederick Ek (insider trades) sold 41,196 shares of GNMK on 09/22/2020 at an average price of $13.82 a share. The total sale was $569,329.


GenMark Diagnostics Inc is a molecular diagnostics company. The Company develops and commercializes its proprietary eSensor detection technology for the support of instruments and molecular tests. GenMark Diagnostics Inc has a market cap of $929.630 million; its shares were traded at around $13.08 with and P/S ratio of 6.31. GenMark Diagnostics Inc had annual average EBITDA growth of 11.90% over the past ten years. GuruFocus rated GenMark Diagnostics Inc the business predictability rank of 2.5-star. GuruFocus has detected 3 severe warning signs with GenMark Diagnostics Inc. .

CEO Recent Trades:

  • President & CEO Scott Mendel sold 50,000 shares of GNMK stock on 08/26/2020 at the average price of $15.02. The price of the stock has decreased by 12.92% since.

CFO Recent Trades:

  • CFO John Frederick Ek sold 41,196 shares of GNMK stock on 09/22/2020 at the average price of $13.82. The price of the stock has decreased by 5.35% since.

  • CFO John Frederick Ek sold 5,723 shares of GNMK stock on 09/16/2020 at the average price of $12.98. The price of the stock has increased by 0.77% since.

Directors and Officers Recent Trades:

  • SVP, Engineering and Tech Dev Tyler Jensen sold 500 shares of GNMK stock on 09/17/2020 at the average price of $12.72. The price of the stock has increased by 2.83% since.

  • SVP, Global Mktg & Int'l Sales Scott Alexander O'brien sold 770 shares of GNMK stock on 09/08/2020 at the average price of $11.02. The price of the stock has increased by 18.69% since.

  • VP, Assay Development Christine Shaw sold 285 shares of GNMK stock on 09/08/2020 at the average price of $11.02. The price of the stock has increased by 18.69% since.

  • SVP, Operations Brian Andrew Mitchell sold 4,000 shares of GNMK stock on 09/08/2020 at the average price of $11.02. The price of the stock has increased by 18.69% since.

  • SVP, Engineering and Tech Dev Tyler Jensen sold 500 shares of GNMK stock on 09/03/2020 at the average price of $12.2. The price of the stock has increased by 7.21% since.

For the complete insider trading history of GNMK, click here

.This article first appeared on GuruFocus.